Currently, we lack treatments that can prevent or slow the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's Disease. One major barrier for researchers is a lack of access to secure and reliable clinical samples and biodata to develop diagnostic tools and therapeutics more effectively.
To address this, EPND is building a scalable and self-sustaining platform to accelerate discovery of diagnostics and therapeutics. When the project is complete, EPND will facilitate access to neurodegenerative disease data and clinical samples from across Europe, representing more than 150,000 research participants. The neurodegenerative disease research community can use this secure, accessible platform in a collective effort to develop diagnostic tools and treatments.
https://epnd.org/